Telomerase stimulates ribosomal DNA transcription under hyperproliferative conditions

Nature Communications

Volumn 5, Issue , 2014, Pages

  Gonzalez, Omar Garcia ^a   Assfalg, Robin ^a   Koch, Sylvia ^a   Schelling, Adrian ^a   Meena, Jitendra K ^b   Kraus, Johann ^c   Lechel, Andre ^a   Katz, Sarah Fee ^a   Benes, Vladimir ^d   Scharffetter Kochanek, Karin ^a   Kestler, Hans A ^c   Günes, Cagatay ^b   Iben, Sebastian ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE; IMETELSTAT; RAS PROTEIN; RIBOSOME DNA; TELOMERASE REVERSE TRANSCRIPTASE; PROTEIN BINDING; TELOMERASE; TERT PROTEIN, HUMAN; TERT PROTEIN, MOUSE;

CELL ORGANELLE; DNA; ENZYME ACTIVITY; INHIBITOR; POLYMERASE CHAIN REACTION; TUMOR;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL TRANSFORMATION; COILED BODY; COMPLEX FORMATION; CONTROLLED STUDY; DNA TRANSCRIPTION; ENZYME BINDING; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER REGENERATION; METHYLATION; NONHUMAN; NUCLEOLUS; PROMOTER REGION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; ANIMAL; C57BL MOUSE; CELL LINE; CELL PROLIFERATION; COLORECTAL TUMOR; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; KIDNEY; LIVER; LUNG; MALE; MOUSE; MYOFIBROBLAST; PATHOLOGY; PHYSIOLOGY; RABBIT; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DNA, RIBOSOMAL; HUMANS; KIDNEY; LIVER; LIVER REGENERATION; LUNG; MALE; MICE; MICE, INBRED C57BL; MYOFIBROBLASTS; PROTEIN BINDING; RABBITS; RNA POLYMERASE I; TELOMERASE; TRANSCRIPTION, GENETIC;

EID: 84907342444     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5599     Document Type: Article

References (41)

1. Stewart, S. A. et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl Acad. Sci. USA 99, 12606-12611 (2002).
2. Martinez, P. & Blasco, M. A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer 11, 161-176 (2011).
3. Park, J. I. et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460, 66-72 (2009).
4. Ghosh, A. et al. Telomerase directly regulates NF-kappaB-dependent transcription. Nat. Cell. Biol. 14, 1270-1281 (2012).
5. Zhong, F. et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev. 25, 11-16 (2011).
6. Chiodi, I. & Mondello, C. Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria. Front. Oncol. 2, 133 (2012).
7. Tomlinson, R. L., Ziegler, T. D., Supakorndej, T., Terns, R. M. & Terns, M. P. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 17, 955-965 (2006). (Pubitemid 43191127)
8. Lee, J. H. et al. Catalytically active telomerase holoenzyme is assembled in the dense fibrillar component of the nucleolus during S phase. Histochem. Cell Biol. 141, 137-152 (2014).
9. Etheridge, K. T. et al. The nucleolar localization domain of the catalytic subunit of human telomerase. J. Biol. Chem. 277, 24764-24770 (2002). (Pubitemid 34952008)
10. Lin, J. et al. Nucleolar localization of TERT is unrelated to telomerase function in human cells. J. Cell. Sci. 121, 2169-2176 (2008).
11. Wu, Y. L. et al. Immunodetection of human telomerase reverse- transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J. Cell. Sci. 119, 2797-2806 (2006).
12. Ritz, J. M. et al. A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues. Cancer Res. 65, 1187-1196 (2005). (Pubitemid 40270143)
13. Taggart, A. K., Teng, S. C. & Zakian, V. A. Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science 297, 1023-1026 (2002). (Pubitemid 34856037)
14. Xin, H. et al. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445, 559-562 (2007). (Pubitemid 46197638)
15. Sirma, H. et al. The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation. Gastroenterology 141, 326-337 (2011).
16. Nguyen, B. N., Elmore, L. W. & Holt, S. E. Mechanism of dominant-negative telomerase function. Cell Cycle 8, 3227-3233 (2009).
17. Lee, J. H. et al. Catalytically active telomerase holoenzyme is assembled in the dense fibrillar component of the nucleolus during S phase. Histochem. Cell Biol. 141, 137-152 (2014).
18. Katz, S. F. et al. Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation. Gastroenterology 142, 1229-1239 (2012).
19. Assfalg, R. et al. TFIIH is an elongation factor of RNA polymerase I. Nucleic Acids Res. 40, 650-659 (2012).
20. Shi, S. et al. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat. Biotechnol. 20, 587-591 (2002). (Pubitemid 34595152)
21. Forsythe, H. L., Elmore, L. W., Jensen, K. O., Landon, M. R. & Holt, S. E. Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage. Int. J. Oncol. 20, 1137-1143 (2002).
22. Gorbunova, V. & Seluanov, A. Telomerase as a growth-promoting factor. Cell Cycle 2, 534-537 (2003).
23. Volarevic, S. et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288, 2045-2047 (2000). (Pubitemid 30397685)
24. Derenzini, M. et al. Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells. J. Cell. Physiol. 202, 483-491 (2005). (Pubitemid 40041319)
25. Drygin, D. et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res. 71, 1418-1430 (2009).
26. Gonzalez-Suarez, E., Flores, J. M. & Blasco, M. A. Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol. Cell. Biol. 22, 7291-7301 (2002).
27. Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E. & de Lange, T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765-3772 (1996). (Pubitemid 26199896)
28. Artandi, S. E. et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl Acad. Sci. USA 99, 8191-8196 (2002). (Pubitemid 34651028)
29. Li, S., Crothers, J., Haqq, C. M. & Blackburn, E. H. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J. Biol. Chem. 280, 23709-23717 (2005). (Pubitemid 40884853)
30. Joseph, I. et al. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res. 70, 9494-9504 (2010).
31. Hahn, W. C. et al. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5, 1164-1170 (1999). (Pubitemid 29474421)
32. Counter, C. M. et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2)The catalytic subunit of telomerase. Oncogene 16, 1217-1222 (1998). (Pubitemid 28127521)
33. Sarin, K. Y. et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436, 1048-1052 (2005). (Pubitemid 41191691)
34. Maida, Y. et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461, 230-235 (2009).
35. Okamoto, N. et al. Maintenance of tumor initiating cells of defined genetic composition by nucleostemin. Proc. Natl Acad. Sci. USA 108, 20388-20393 (2011).
36. Shkreli, M. et al. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat. Med. 18, 111-119 (2012).
37. Ding, D., Zhou, J., Wang, M. & Cong, Y. S. Implications of telomereindependent activities of telomerase reverse transcriptase in human cancer. FEBS J. 280, 3205-3211 (2013).
38. Zhou, J., Ding, D., Wang, M. & Cong, Y. S. Telomerase reverse transcriptase in the regulation of gene expression. BMB Rep. 47, 8-14 (2014).
39. Ruggero, D. et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299, 259-262 (2003). (Pubitemid 36125213)
40. O'Sullivan, A. C., Sullivan, G. J. & McStay, B. UBF binding in vivo is not restricted to regulatory sequences within the vertebrate ribosomal DNA repeat. Mol. Cell. Biol. 22, 657-668 (2002). (Pubitemid 34027509)
41. Higgins, G. M. & Anderson, R. M. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12, 186-202 (1931).